James River Group Holdings (JRVR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Reported a Q3 2024 net loss from continuing operations of $40.7 million ($1.07 per diluted share), driven by $57.0 million of adverse reserve development and a $52.2 million charge from a new reinsurance contract, alongside a strategic partnership with Enstar Group involving a $12.5 million equity investment and a $75 million adverse development cover.
Adjusted net operating loss was $28.2 million ($0.74 per diluted share), primarily due to reserve charges and reinsurance actions.
Board concluded the strategic review process, expressing confidence in future shareholder value creation and ongoing evaluation of beneficial opportunities.
Announced intent to redomicile to the U.S. in 2025 to lower the effective tax rate.
Sale of JRG Reinsurance Company Ltd. closed in April 2024, resulting in discontinued operations and a $2.7 million loss on disposal.
Financial highlights
Gross written premiums were $330.4 million in Q3 2024, down 4% year-over-year; net written premiums increased 1% to $147.3 million.
Net earned premiums declined 13% to $159.7 million.
Net investment income rose 8.1% year-over-year to $23.6 million, with a stable book yield of 4.4%.
Net realized and unrealized investment gains were $4.2 million in Q3 2024.
No net catastrophe losses reported for Q3 in either E&S or Specialty Admitted segments.
Outlook and guidance
Management is optimistic about future profitability, citing strong underwriting conditions and robust submission growth.
Redomiciling to the U.S. expected to reduce the effective tax rate closer to the U.S. statutory rate.
Expense ratio expected to normalize around 28% going forward.
High single-digit loss trend assumed for 2024, with ongoing review for 2025.
Strategic actions, including capital raise and reinsurance, position the E&S franchise to capitalize on robust market conditions.
Latest events from James River Group Holdings
- Net loss of $10.9M driven by E&S reinsurance charge; E&S segment led growth amid lower premiums.JRVR
Q1 202614 May 2026 - 2025 marked a sharp turnaround to profitability, capital growth, and E&S-driven operational gains.JRVR
Q4 202527 Mar 2026 - Earnings rose on investment gains and strategic actions, but reserve and legal risks persist.JRVR
Q2 20242 Feb 2026 - Over 21 million common shares registered for resale by major investors, with no proceeds to the company.JRVR
Registration Filing16 Dec 2025 - Q4 2024 net loss of $92.7M; E&S premiums top $1B; 2025 outlook positive.JRVR
Q4 202416 Dec 2025 - Annual Meeting to vote on directors, auditor, compensation, and incentive plan amendments.JRVR
Proxy Filing2 Dec 2025 - Proxy covers director elections, auditor re-appointment, compensation, and plan amendments.JRVR
Proxy Filing2 Dec 2025 - Q1 net income dropped to $9M as E&S pricing rose and Specialty Admitted premiums declined.JRVR
Q1 202524 Nov 2025 - Q2 2025 saw $11.7M adjusted net income, 14% return, and record E&S premiums amid strategic changes.JRVR
Q2 202523 Nov 2025